0001127602-24-005073.txt : 20240214
0001127602-24-005073.hdr.sgml : 20240214
20240214171441
ACCESSION NUMBER: 0001127602-24-005073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Havanec Laurie P.
CENTRAL INDEX KEY: 0001807757
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 24640521
MAIL ADDRESS:
STREET 1: ONE CARRIER PLACE
CITY: FARMINGTON
STATE: CT
ZIP: 06032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-02-12
0000064803
CVS HEALTH Corp
CVS
0001807757
Havanec Laurie P.
ONE CVS DRIVE
WOONSOCKET
RI
02895
1
EVP and Chief People Officer
0
Common Stock
2024-02-12
4
A
0
16817
0
A
37203
D
Common Stock (Restricted)
14678
D
Stock Option
74.30
2022-04-01
2031-04-01
Common Stock
27643
27643
D
Stock Option
101.09
2023-04-01
2032-04-01
Common Stock
21829
21829
D
Stock Option
74.31
2024-04-01
2033-04-01
Common Stock
51959
51959
D
Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
Option became exercisable in four equal installments, commencing 4/1/2022.
Option became exercisable in four equal installments, commencing 4/1/2023.
Option becomes exercisable in four equal installments, commencing 4/1/2024.
/s/ Laurie P. Havanec
2024-02-13